TetraLogic Pharmaceuticals Corporation
TLOG
TLOG was delisted on the 3rd of November, 2016.
31 hedge funds and large institutions have $10.2M invested in TetraLogic Pharmaceuticals Corporation in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
7% more funds holding
Funds holding: 29 → 31 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less capital invested
Capital invested by funds: $11.5M → $10.2M (-$1.33M)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$46.9K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.6K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$25.3K |
| 4 |
Goldman Sachs
New York
|
+$24.6K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
-$221K |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$208K |
| 3 |
Bank of New York Mellon
New York
|
-$190K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$171K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$50.5K |
TLOG Hedge Fund Activity: Q4 2015 in Review
31 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q4 2015, worth a combined $10.2M — down 12% from $11.5M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new TLOG positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $46.9K. The largest seller was First Eagle Investment Management, cutting an estimated $221K.
- 31 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q4 2015, up from 29 in Q3 2015.
- Funds reported $10.2M of TetraLogic Pharmaceuticals Corporation stock for Q4 2015, down 12% quarter-over-quarter.
- 5 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q4 2015 and 3 closed out, a net change of +2 holders.
- The largest TetraLogic Pharmaceuticals Corporation buyer in Q4 2015 was Renaissance Technologies, an estimated $46.9K added.
- The largest TetraLogic Pharmaceuticals Corporation seller in Q4 2015 was First Eagle Investment Management, an estimated $221K sold.
Based on aggregated 13F filings for Q4 2015.